小分子对抗阿尔茨海默病的线粒体向:一种机械学观点
1Department of Chemistry, Gobardanga Hindu College, North 24 Parganas, West Bengal 743273, India.
Biochimica et biophysica acta. Molecular basis of disease
|December 8, 2024
概括
针对线粒体的小分子为阿尔茨海默病 (AD) 提供了一个有前途的治疗策略. 这种方法旨在恢复线粒体功能,并对抗AD患者的神经退行.
科学领域:
- 神经科学是一个神经科学.
- 线粒体生物学 线粒体生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 阿尔茨海默病 (AD) 是一种进展性神经退行性疾病,治疗选择有限.
- 以氧化应激和能量代谢受损为特征的线粒体功能障碍是AD病变发生的关键因素.
- 线粒体功能障碍有助于AD病态的标志性特征,如粉样斑块和神经纤维状,导致突触功能障碍和神经元死亡.
研究的目的:
- 审查线粒体功能障碍在阿尔茨海默病中的机械作用.
- 探索基于小分子的治疗策略,针对AD的线粒体.
- 总结当前的前临床和临床证据,以对抗阿尔茨海默病的线粒体向疗法.
主要方法:
- 在AD中对线粒体功能障碍的机械方面进行文献综述.
- 对氧化应激对线粒体组件的影响分析.
- 检查针对线粒体通路的小分子干预措施.
主要成果:
- 线粒体功能障碍与β-粉样斑块和神经纤维细胞的积累有关.
- 氧化应激显著损害线粒体组件,加剧AD病理.
- 小分子显示出恢复线粒体功能和减轻AD进展的潜力.
结论:
- 用小分子准线粒体功能障碍代表了阿尔茨海默病的有希望的治疗途径.
- 对分子途径和小分子干预的进一步研究对于开发有效的AD治疗至关重要.
- 针对线粒体的治疗有可能恢复神经元功能并减少AD病理.
相关概念视频
Alzheimer's Disease: Treatment
163
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
163
Electron Transport Chain: Complex I and II
11.5K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
11.5K
Alzheimer's Disease: Overview
447
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
447
Mitochondria
10.9K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
10.9K
siRNA - Small Interfering RNAs
16.6K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.6K
Translocation of Proteins into the Mitochondria
3.0K
Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
3.0K


